Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) is an arrhythmogenic disease characterized by stress-triggered syncope and sudden death. Most of the CPVT mutations are concentrated in RyR ''hotspots'': the C terminus, the central and the N terminal domains. Although the phenotypic manifestations are common, it is likely that the intrinsic mechanism of RyR dysfunction varies with the location of the mutation within the RyR. Previously, we characterized RyR dysfunction in a CPVT mutation located at the C terminal domain, identifying an increased cytosolic Ca 2þ sensitivity as the causative of a gain-of-funcion defect. Recently, we have identified a mutation in a family with CPVT syndrome, which is located in the N University of Rochester, Rochester, NY, USA. Malignant hyperthermia (MH) is a severe hypermetabolic response triggered by exposure to volatile anesthetics and caused by mutations in the genome of ryanodine receptor subtype 1 (RYR1) in the skeletal muscle. The presence of mitochondrial ryanodine receptor (mRYR) in heart, which behaves immunologically and pharmacologically like RyR1, raises the question of its primary cardiac pathological role in MH. To address this, we used genetically modified micecontaining RyR1 with a single point mutation at the position 522 (tyrosine versus serine; YS mice, obtained from Dr. Susan Hamilton, Baylor College of Medicine) and wild type (WT) mice. Ca 2þ uptake of isolated heart mitochondria from both animal groups was measured (N=3) using ArsenazoIII. Our data show, that in 1 year old YS mice, the total free Ca 2þ load tolerated before full mitochondrial permeability transition pore (mPTP) opening was lower (275.22542.4 nmol free Ca 2þ / mg protein) compared to WT (474.77565.7 nmol free Ca 2þ / mg protein). The time constant (T), calculated from the velocity of Ca 2þ uptake during the first 2 minutes after applying a 5mM Ca 2þ pulse was not significantly different in YS than in WT. However, significant differences were observed using RYR1 specific inhibitors (10mM dantrolene and 10mM azumolene). In presence of these inhibitors, WT showed a prolonged T (383.09541.65sec with dantrolene and 305.75538.52sec with azumolene) suggesting that mRYR was inhibited. Surprisingly, YS showed less inhibition due to the difficulty of blocking leaky channel (265.55526.07sec and 202.56531.45sec respectively). Measuring the membrane potential with TMRE showed that baseline fluorescence of YS mitochondria was significantly lower, indicating that these mitochondria are depolarized (1.6150.02a.u. versus 1.9350.02a.u. in WT, P<0.05). Depolarized mitochondrial membranes due to leaky mRYR suggest a primary role of this protein in heart pathology in MH.
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Dantrolene-Sensitive Mitochondrial Ca2D Uptake under Mitochondrial Ca2D Uniporter Inhibition Shi Pan, Nadan Wang, Polina Gross, Jin O-uchi, Shey-Shing Sheu. Thomas Jefferson University, Philadelphia, PA, USA. Intracellular Ca2þ is vital for cell physiology. Disruption of Ca2þ homeostasis contributes to human diseases such as heart failure, neuron-degeneration, and diabetes. The central role of mitochondrial Ca2þ is to regulate energy production and shape the amplitude and duration of Ca2þ transients. In responding to physiological Ca2þ pulses, mitochondria take up Ca2þ through the activation of influx mechanisms in the inner membrane, such as mitochondrial Ca2þ unipoter (MCU), and mitochondrial ryanodine receptor (mRyR). Dantrolene is a pharmacological compound used clinically for the treatment of malignant hyperthermia by blocking RyR. Our recent studies have shown that mRyR is sensitivity to dantrolene, but not to ruthenium red 360 (Ru360), which is a known inhibitor of MCU. Therefore, we studied the mechanisms for mitochondrial Ca2þ uptake in the existence of MCU inhibitor Ru360 and mRyR inhibitor dantrolene. Cardiac mitochondria isolated from C57BL/6 mice were incubated with dantrolene (10 mM), Ru360 (50 nM), or both Ru360 and dantrolene. Mitochondrial Ca2þ uptake was measured using a fluorometer with Calcium Green added in the assay solutions. Ru360 significantly blocked mitochondrial Ca2þ uptake. However, there still existed a small but statistically significant transient Ca2þ uptake component. This transient Ca2þ uptake component was inhibited by dantrolene. Our results demonstrate a dantrolene-sensitive Ca2þ uptake mechanism in cardiac mitochondria. This Ca2þ uptake mechanism appears to be faster and transient in comparison to that of MCU. Chem., 2008) . However, the molecular components involved in the physical coupling remain to be elucidated. In the present study, we identified VDAC2 as a putative binding partner for RyR2 in SR by the bacterial twohybrid screening. The interaction of VDAC2 with RyR2 was further confirmed by GST-pull down and co-immunoprecipitation assays. As tethering structures between SR and mitochondria was detected in cardiomyocytes (Boncompagni et al., Mol. Biol. Cell., 2009), we identified a close apposition between mitochondria and SR in HL-1 cells by electron microscopic study. With the immuno-gold labeling strategy, furthermore, the co-localization of VDAC2 with RyR2 at the junction between SR and mitochondria was revealed at sub-micrometer resolution. In adult ventricular cardiomyocytes, the association of VDAC2 and RyR2 was detected at the sub-sarcolemmal region according to immunocytochemical study and differential centrifugations. To investigate the roles of VDAC2 in cardiomyocytes, we attempted to use adenovirus-based shRNA system to knock down VDAC2 gene expression. A numerical model of the rabbit ventricular cardiomyocyte is developed, that properly reproduces calcium alternans at high pacing frequency and experimental postrest-potentiation. We show that calcium alternans may appear due to the alternation in the number of RyR2 ready to open before each beat and not, despite the fact they are present, to oscillations in the SR Ca load. This mechanism is present when activation rates of RyR2 are low and is also favored by a slowing of the RyR2 recovery time from inactivation. Generally, changes in RyR2 refractoriness lead to alternans via two different mechanisms, (the already established) SR Ca2þ load and (a new one) recovery form inactivation. Drugs or mutations which target RyR2 refractoriness should be arrythmogenic via the activation of one of those mechanisms if they decrease the activation or inactivation rate. 308a Monday, February 27, 2012 
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